GOLDMAN SACHS GROUP INC - MEDICINES CO ownership

MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 206 filers reported holding MEDICINES CO in Q3 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of MEDICINES CO
ValueSharesWeighting
Q4 2019$90,191,000
+157.4%
1,061,818
+51.5%
0.02%
+120.0%
Q3 2019$35,043,000
+11.7%
700,874
-18.5%
0.01%
+11.1%
Q2 2019$31,373,000
+49.4%
860,231
+14.5%
0.01%
+50.0%
Q1 2019$21,005,000
+26.6%
751,507
-13.3%
0.01%
+20.0%
Q4 2018$16,598,000
+11.1%
867,241
+73.6%
0.01%
+66.7%
Q3 2018$14,942,000
-49.4%
499,549
-37.9%
0.00%
-57.1%
Q2 2018$29,528,000
+16.6%
804,564
+4.7%
0.01%
+16.7%
Q1 2018$25,320,000
-27.1%
768,649
-39.5%
0.01%
-25.0%
Q4 2017$34,722,000
-70.7%
1,270,004
-60.4%
0.01%
-72.4%
Q3 2017$118,706,000
+29.0%
3,204,759
+32.4%
0.03%
+26.1%
Q2 2017$92,033,000
-17.0%
2,421,281
+6.8%
0.02%
-23.3%
Q1 2017$110,856,000
+263.7%
2,266,979
+152.4%
0.03%
+233.3%
Q4 2016$30,484,000
+26.5%
898,177
+40.6%
0.01%
+28.6%
Q3 2016$24,103,000
-29.5%
638,673
-37.2%
0.01%
-36.4%
Q2 2016$34,202,000
-23.5%
1,017,021
-27.7%
0.01%
-26.7%
Q1 2016$44,714,000
+52.0%
1,407,409
+78.7%
0.02%
+66.7%
Q4 2015$29,412,000
-52.6%
787,699
-51.9%
0.01%
-57.1%
Q3 2015$62,105,000
+169.5%
1,636,056
+103.1%
0.02%
+200.0%
Q2 2015$23,044,000
+11.3%
805,453
+9.0%
0.01%0.0%
Q1 2015$20,710,000
+65.3%
739,108
+63.2%
0.01%
+75.0%
Q4 2014$12,532,000
+109.0%
452,900
+68.6%
0.00%
+100.0%
Q3 2014$5,996,000
-66.2%
268,627
-56.0%
0.00%
-66.7%
Q2 2014$17,760,000
-11.7%
611,158
-13.7%
0.01%0.0%
Q1 2014$20,118,000
+20.3%
707,871
+63.4%
0.01%
+20.0%
Q4 2013$16,727,000
+45.7%
433,123
+26.5%
0.01%0.0%
Q3 2013$11,477,000
+8.3%
342,413
-0.6%
0.01%
+25.0%
Q2 2013$10,595,000
+23.9%
344,445
-3.4%
0.00%0.0%
Q4 2012$8,551,000
-32.4%
356,727
-27.3%
0.00%0.0%
Q3 2012$12,658,000
+209.5%
490,439
+175.1%
0.00%
+100.0%
Q2 2012$4,090,000
+773.9%
178,247
+663.2%
0.00%
Q1 2012$468,00023,3560.00%
Other shareholders
MEDICINES CO shareholders Q3 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,202,000$356,917,00029.62%
SYQUANT CAPITAL SAS 505,030$42,897,00022.09%
Moab Capital Partners 521,987$44,338,00017.51%
Antipodean Advisors LLC 321,000$27,266,00015.60%
RAMIUS ADVISORS LLC 419,826$35,660,00015.34%
DLD Asset Management, LP 3,275,900$278,255,00015.00%
Foresite Capital Management IV, LLC 403,217$34,249,00014.78%
WHITE SQUARE CAPITAL LLP 239,331$20,329,00014.70%
Davide Leone & Partners Investment Co Ltd. 1,146,192$97,358,00012.50%
Quad Capital Management Advisors LLC 8,640$734,00011.19%
View complete list of MEDICINES CO shareholders